DetailsChartProfileRisk matrixNewsDocuments

MAGELLAN I/  FR0011238344  /

Fonds
NAV9/5/2024 Chg.+0.0400 Type of yield Investment Focus Investment company
20.5000EUR +0.20% reinvestment Equity Emerging Markets Comgest ▶
GlobeNewswire 8/29 Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a ...
GlobeNewswire 8/28 Giant Magellan Telescope Mount Fabrication Begins
GlobeNewswire 8/20 Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended ...
GlobeNewswire 8/8 Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
GlobeNewswire 8/5 Diamondback Energy, Inc. Announces Second Quarter 2024 Financial and Operating Results
GlobeNewswire 8/1 Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference
GlobeNewswire 7/16 Howard Hughes Holdings Inc. Appoints Bhupesh Arora as Chief Technology Officer
GlobeNewswire 7/9 Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Pha...
GlobeNewswire 6/28 Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
GlobeNewswire 6/28 Michael Braham appointed CareSource Military & Veterans president
GlobeNewswire 6/27 Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
GlobeNewswire 6/27 Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) For...
GlobeNewswire 6/25 Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire 6/14 Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
GlobeNewswire 6/13 Gain Therapeutics Announces Proposed Public Offering
GlobeNewswire 6/13 Giant Magellan Telescope Enclosure Ready for Construction
GlobeNewswire 5/30 Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federati...
GlobeNewswire 5/14 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 5/14 Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire 4/24 Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire 4/8 Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...
GlobeNewswire 4/1 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 3/27 Cegedim Full year 2023 results: Revenue and recurring operating income both up
GlobeNewswire 3/26 Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
GlobeNewswire 3/15 Gain Therapeutics to Present at Public Ventures Discovery Day